Reference health

Andexanet alfa: A Novel Factor Xa Inhibitor Reversal Agent

https://doi.org/10.1177/1060028019835209
CiteStamped reference-health badge
13/13 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

1 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 13 checked references that resolve
resolves10.2147/VHRM.S121661
Evaluation of bleeding in patients receiving direct oral anticoagulants
resolves10.1056/NEJMoa1607887
Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors
resolves10.1155/2014/583794
Management of the Bleeding Patient Receiving New Oral Anticoagulants: A Role for Prothrombin Complex Concentrates
resolves10.1016/j.amjmed.2015.05.044
National Trends in Ambulatory Oral Anticoagulant Use
resolves10.1007/978-1-62703-339-8_19
Anti-factor Xa (Anti-Xa) Assay
resolves10.1038/nm.3102
A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa
resolves10.1056/NEJMoa1510991
Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity
resolves10.1182/bloodadvances.2017007112
Safety, pharmacokinetics, and reversal of apixaban anticoagulation with andexanet alfa
resolves10.1111/jth.12864
Safety and pharmacokinetics of anti‐TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial
resolves10.1016/j.ajem.2016.03.019
Letter in response to “Superwarfarin ingestion treated successfully with prothrombin complex concentrate”
resolves10.1007/s11239-018-1617-2
Andexanet alfa to reverse the anticoagulant activity of factor Xa inhibitors: a review of design, development and potential place in therapy
resolves10.1371/journal.pone.0195122
Andexanet alfa effectively reverses edoxaban anticoagulation effects and associated bleeding in a rabbit acute hemorrhage model
resolves10.1016/j.thromres.2017.12.003
Current evidence of oral anticoagulant reversal: A systematic review
The 1 reference without a DOI — listed, not checked
no DOI — not checkedAndexXa [package insert]. South San Francisco, CA: Portola Pharmaceuticals Inc; 2018.
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1177/1060028019835209"><img src="https://citestamp.com/citestamped/10.1177/1060028019835209/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1177/1060028019835209/badge.svg)](https://citestamp.com/citestamped/10.1177/1060028019835209)